A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Clinical trial NCT06194877 · TERMINATED

Trial details

NCT number: NCT06194877
Sponsor: MapKure, LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Pancreatic Ductal Cancer Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Start date: 2024-04-18
Primary completion: 2025-03-10
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.